Return from Madness : Psychotherapy with People Taking the New Antipsychotic Medications and Emerging from Severe, Lifelong, and Disabling Schizophrenia

The advent of novel antipsychotic medications has created a need for psychotherapy.

By the mid-eighties, the provision of psychotherapy for people who could not get out of bed, bathe, get dressed, prepare meals, and manage their own money had diminished. Treatment centered on case management and rehabilitation. This virtual elimination of psychotherapy made sense economically as well as therapeutically: traditional psychotherapy had little success with people suffering from schizophrenia. However, the advent of novel antipsychotic medications has created a need for psychotherapy tailored to this population. Sudden reduction in pervasive, persistent delusions and hallucinations, and recovery of motivation, energy, volition, and the ability to experience pleasure from something other than cigarettes is a mixed blessing. Patients are relieved of terrible suffering but left with new problems. Shedding the lifelong identity of a mental patient, they no longer need case management but require help adjusting to major changes in their thinking and functioning. Kathleen Degen and Ellen Nasper describe group therapy that helps patients identify and cope with unexpected, intense feelings such as sadness or painful memories of childhood trauma, increase their interpersonal skills, and advance their sense of self beyond that of their label as mental patients. The authors show how to build on the phenomenal changes that the new medications provide.